Skip to main content
. Author manuscript; available in PMC: 2019 Jan 11.
Published in final edited form as: Adv Anat Pathol. 2009 Nov;16(6):392–404. doi: 10.1097/PAP.0b013e3181bb6bc2

TABLE 2.

Immunophenotypic Profiles of Normal PDCs, “Tumor Forming” PDC Proliferations Associated With Myeloid Neoplasms, and BPDCN

Antigen Normal
PDCs
“Tumor
forming” PDC
Proliferations
BPDCN

CD123 + + +
TCL1 + + +
CD4 + + +
CD56 * ± +
TdT ±
Ki-67 <5% < 10% > 30%
*

Positivity reported in a small subset of circulating PDCs.

Usually negative but may show focal positivity.

Negative cases extremely rare.

BPDCN indicates blastic plasmacytoid dendritic cell neoplasm; PDC, plasmacytoid dendritic cell; TCL, T-cell leukemia/lymphoma; TdT, terminal deoxynucleotidyl transferase.